U.S. panel suggests limited approval for antipsychotic drug

Tuesday, April 7, 2009 - 17:28 in Health & Medicine

The U.S. Food and Drug Administration should consider approving a drug for people with schizophrenia who don't respond to other treatments, an advisory panel said Tuesday.

Read the whole article on CBC: Health

More from CBC: Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net